We are selective about the tests included in AncestryHealth. We focus on tests for specific genetic variants that:
For example, AncestryHealth includes testing for genetic variants associated with familial hypercholesterolemia (FH):
Genotyping technology looks for specific genetic variants present in an individual’s DNA. Some of these variants, also referred to as mutations, can lead to an increased risk of pathological changes underlying certain conditions. The custom genotyping array (or chip) technology used by our independent laboratory partners analyzes hundreds of thousands of variants throughout the human genome, including hundreds that provide insight into risk to develop certain health conditions.
Analytical validity refers to the ability of a test to accurately detect whether a specific genetic variant is present or absent.
Clinical validity refers to how well the specific genetic variant being analyzed is related to the risk of developing a certain condition.
The tests included in AncestryHealth are developed and validated by our independent CLIA-certified laboratory partners in accordance with recommendations from the Association for Molecular Pathology and the American College of Medical Genetics.3
Variant coverage refers to the proportion of genetic variants with established association with certain conditions that a test would detect. Variant coverage is variable—by condition, and by ethnicity within each condition.
Variant coverage is clearly outlined in each report as well as in the laboratory report. In addition, this information is published here.
The tests included in AncestryHealth may be considered as an opportunity to identify a genetic risk for certain health conditions. However, this test should not be considered to identify all genetic variants associated with a condition and/or rule out any condition. This is an even more important consideration for conditions that are caused by a large number of variants as genotyping technology assays only a subset of these variants.
Ancestry is committed to an ongoing effort to ensure that our customers understand the key concepts of each AncestryHealth report.
AncestryHealth reports are developed to be both scientifically accurate and easy to understand. For ease of understanding, reports are written in plain English as measured by an 8th grade reading level with Flesch–Kincaid readability tests.
AncestryHealth reports are tested for user comprehension. User comprehension studies are conducted with a large group of nationwide non-customer participants, administered in a real-life online setting. AncestryHealth reports are read by participants who then answer comprehension questions about the reports via an online survey. Participants’ understanding is assessed on key concepts such as: purpose of the test, risks, limitations, other health risk factors, and next steps.
AncestryHealth® includes laboratory tests developed and performed by an independent CLIA-certified laboratory partner, and with oversight from an independent clinician network of board-certified physicians and genetic counselors. The test results are not diagnostic and do not determine a customer’s overall chance of developing a disease or health condition. The tests are not cleared or approved by the U.S Food and Drug Administration. Customers should consult a healthcare provider before taking any action based on AncestryHealth® reports, including before making any treatment, dietary, or lifestyle changes. AncestryHealth® is not currently available in New York, New Jersey, or Rhode Island.